Stopping semaglutide before a stomach scope
Part of Digestive system clinical trials.
This study looks at whether stopping semaglutide for one week before a sedated endoscopy improves how well the stomach is seen and how quickly it empties. It may help doctors better understand how this medicine affects the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be having a painless (sedated) endoscopy (a camera test of your stomach).
- If you take semaglutide (a weekly injection for diabetes or weight loss), you must stop it for 1 week before the test, with the last dose 8–14 days before the procedure.
- If you have never used semaglutide, you can also join.
- If you have diabetes, your blood sugar must be well controlled (HbA1c less than 9%).
- You must fast for at least 8 hours and skip water for at least 4 hours before the endoscopy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether nerve damage from diabetes affects how long semaglutide (a diabetes medicine) stays in the stomach, which can cause stomach retention. It may help doctors understand who is more likely to have this side effect.
This study looks at whether stopping a type 2 diabetes medication called GLP-1 receptor agonists for two weeks before an upper endoscopy can reduce the risk of food staying in the stomach during the procedure. If you are scheduled for an upper endoscopy and take this medication, this trial may help make your procedure safer and more comfortable.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This study tests whether taking semaglutide (a once-weekly injection that helps control appetite and blood sugar) before and after a second weight-loss surgery can help people who regained weight after an initial sleeve gastrectomy. The goal is to see if the medicine improves weight-loss outcomes compared to surgery alone.
This trial is testing whether stopping GLP-1 receptor agonists or tirzepatide one week before an upper endoscopy (a scope that looks at your stomach and esophagus) is safe and effective. It's designed for people who are already taking these medications and have an upcoming procedure.
This study tests a high dose of semaglutide (a medicine used for weight management) to see how it affects stomach emptying in people with excess weight. Participating may help understand how this treatment works and could lead to better options for weight loss.
Hear when a new Gastric Retention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.